Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seltorexant Phase 2b in Insomnia Disorder
NCT03375203Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Nov 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of seltorexant in insomnia disorder, sponsored by Janssen Pharmaceutical. Started Nov 2017; status: completed.
02
Drugs
seltorexant
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT03375203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03375203.